ClearPoint Neuro, Inc.
CLPT Nasdaq
SEC CIK 1285550
Follow ClearPoint Neuro
Weekly email: filings, results, news
Revenue, last quarter
$10.9M
+18.1% vs same quarter last year
Net income
−$11.3M
−94.2% vs same quarter last year
EPS, diluted
−$0.38
−81% vs same quarter last year
Operating cash flow
−$7M
−174.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $37M | −$25.5M |
| FY24 | $31.4M | −$18.9M |
| FY23 | $24M | −$22.1M |
| FY22 | $20.6M | −$16.4M |
| FY21 | $16.3M | −$14.4M |
| FY20 | $12.8M | −$6.8M |
| FY19 | $11.2M | −$5.5M |
| FY18 | $7.4M | −$6.2M |
| FY17 | $7.4M | −$7.2M |
| FY16 | $5.7M | −$8.1M |
| FY15 | $4.6M | −$8.4M |
| FY14 | $3.6M | −$4.5M |
| FY13 | $3.9M | −$7.1M |
| FY12 | $5.1M | −$5.9M |
| FY11 | $3.8M | −$8.3M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 61.4% | −65.4% | −69.1% |
| FY24 | 60.9% | −62.9% | −60.3% |
| FY23 | 56.8% | −93.7% | −92.2% |
| FY22 | 65.8% | −79.5% | −80% |
| FY21 | 68.2% | −82.1% | −88.4% |
| FY20 | 71.1% | −48.5% | −52.9% |
| FY19 | 64.9% | −41% | −49.4% |
| FY18 | 66.9% | −71.4% | −83.8% |
| FY17 | 60.7% | −85.9% | −97.1% |
| FY16 | 54% | −130.3% | −140.4% |
| FY15 | 56.7% | −195.3% | −183.9% |
| FY14 | 46.5% | −147.6% | −125.5% |
| FY13 | 63.8% | −190.2% | −180.3% |
| FY12 | 89% | −61.9% | −116.2% |
| FY11 | 82.8% | −155.1% | −217.7% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$24.4M |
| FY24 | −$9.2M |
| FY23 | −$14.4M |
| FY22 | −$16.4M |
| FY21 | −$12.9M |
| FY20 | −$7.8M |
| FY19 | −$2.9M |
| FY18 | −$4.7M |
| FY17 | −$6M |
| FY16 | −$5.9M |
| FY15 | −$8.7M |
| FY14 | −$7.3M |
| FY13 | −$7.9M |
| FY12 | −$7.6M |
| FY11 | −$6.3M |
- ClearPoint Neuro
- Healthcare median
Show the numbers
| Year | ClearPoint Neuro | Healthcare median |
|---|---|---|
| FY25 | −69.1% | 9.8% |
| FY24 | −60.3% | 10.5% |
| FY23 | −92.2% | 5.3% |
| FY22 | −80% | 12.7% |
| FY21 | −88.4% | 10.8% |
| FY20 | −52.9% | - |
| FY19 | −49.4% | - |
| FY18 | −83.8% | - |
| FY17 | −97.1% | - |
| FY16 | −140.4% | - |
| FY15 | −183.9% | - |
| FY14 | −125.5% | - |
| FY13 | −180.3% | - |
| FY12 | −116.2% | - |
| FY11 | −217.7% | - |
News
No stories filed under ClearPoint Neuro yet - coverage appears here as the news feed clusters it.